Notice of Change to Key Date for PAR-19-167 "Development and Validation of Advanced Mammalian Models for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)".
Notice NOT-NS-19-047 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2019 Category: Research Source Type: funding
Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-19-015 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose the comprehensive functional validation of newly identified therapeutic target candidates for Alzheimer's Disease-Related Dementias (ADRDs). This FOA seeks to promote critical target validation approaches to help de-risk subsequent translational research and accelerate the advancement of novel therapies for ADRD. Target(s) or molecular pathway(s) to be considered for validation must have been already identified using tissue expression or genetic data generated in human samples. In its initial phase, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 6, 2019 Category: Research Source Type: funding
Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-013 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications proposing research on the specific role of aging biology in the development, etiology and treatment of Alzheimer's disease. Aging is by far the main risk factor for most chronic diseases, a fact recognized by the field of geroscience. Recent advances in the fields of basic aging biology and geroscience now allow researchers to address mechanistically the role of aging in Alzheimers disease. Applications that make use of geroscience principles and test the role of different hallm...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 5, 2019 Category: Research Source Type: funding
Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications proposing research on the specific role of aging biology in the development, etiology and treatment of Alzheimer's disease. Aging is by far the main risk factor for most chronic diseases, a fact recognized by the field of geroscience. Recent advances in the fields of basic aging biology and geroscience now allow researchers to address mechanistically the role of aging in Alzheimers disease. Applications that make use of geroscience principles and test the role of different hallm...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 5, 2019 Category: Research Source Type: funding
Neuropathological Assessment of TBI-related Neurodegeneration and Neurocognitive decline - Center Without Walls (NATBI CWOW) (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-19-030 from the NIH Guide for Grants and Contracts. This FOA invites applications for a multisite study to comprehensively characterize the neuropathological features associated with neurodegeneration and neurocognitive decline in persons with a history of traumatic brain injury (TBI). Investigations should elucidate the contribution of key individual (sex, age at time of injury, time since injury, etc) and injury characteristics (injury severity and frequency) to describe associations between neuropathological burden and antemortem clinicopathologic symptoms, and outline the prevalence of TBI...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 25, 2019 Category: Research Source Type: funding
Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States Including in Health Disparities Populations (U19 Clinical Trial not Allowed)
Funding Opportunity RFA-NS-19-012 from the NIH Guide for Grants and Contracts. The National Institute of Neurological Disorders and Stroke (NINDS) and National Institute on Aging (NIA) intend to publish a Funding Opportunity Announcement (FOA) to solicit applications for a large prospective clinical research study to determine the specific subsets of stroke events that predict cognitive impairment and dementia in post-stroke populations in the United States, including in health disparities populations, and what additional clinical factors and comorbidities along the AD/ADRD spectrum may causally synergize with stroke to...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 15, 2019 Category: Research Source Type: funding
Alzheimer's Disease Programs Initiative - Grants to States and Communities
Grants to support the development and expansion of dementia-capable home and community-based service systems in states and communities. Geographic coverage: Nationwide -- Administration for Community Living, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - February 5, 2019 Category: American Health Source Type: funding
Human Three-Dimensional Cell Model Systems for Alzheimers Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-19-027 from the NIH Guide for Grants and Contracts. This FOA invites applications that propose to develop, characterize and validate innovative human cellular model systems that recapitulate phenotypic, mechanistic and neuropathological hallmarks of Alzheimers Disease-Related Dementias (ADRDs). Model systems will be expected to capture the complex, multi-faceted proteinopathies and/or vascular pathology observed in ADRDs, with multiple cell types represented in each model. Years 3-5 will focus on the extensive characterization and perturbation of the cellular model systems. The overall goal of...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 29, 2019 Category: Research Source Type: funding
Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-167 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages research to develop, characterize and validate innovative mammalian models that recapitulate molecular, cellular, neuropathological, behavioral and cognitive hallmarks of the Alzheimers Disease-Related Dementias (ADRD), including Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), frontotemporal degeneration (FTD) and mixed etiology dementias (MED). Models will be expected to exhibit a broad range of features characteristic of the dementia disorder b...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 23, 2019 Category: Research Source Type: funding
Notice of Participation of the National Institute on Minority Health and Health Disparities (NIMHD) in PAR-19-071, Research on Current Topics in Alzheimers Disease and its Related Dementias (R21 Clinical Trial Not Allowed)
Notice NOT-MD-19-017 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 11, 2019 Category: Research Source Type: funding
Notice of Participation of the National Institute on Minority Health and Health Disparities (NIMHD) in PAR-19-070, Research on Current Topics in Alzheimers Disease and its Related Dementias (R01 Clinical Trial Optional)
Notice NOT-MD-19-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 11, 2019 Category: Research Source Type: funding
Clarification of the Award Period for NOT-AG-18-039, "Alzheimer's-focused administrative supplements for NIH grants that are not focused on Alzheimer's disease"
Notice NOT-AG-18-055 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2018 Category: Research Source Type: funding
Notice of Correction to Advisory Council Review Dates for PAR-19-070 and PAR-19-071, "Research on Current Topics in Alzheimer's Disease and Its Related Dementias"
Notice NOT-AG-18-054 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2018 Category: Research Source Type: funding
Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional)
Funding Opportunity RFA-NS-19-014 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) supports the development of PET radioligands that identify proteinopathies or pathological processes associated with the human biology of Alzheimer's disease related dementias (ADRDs). Activities supported under this FOA include, but are not limited to the in vitro screening of existing ligands against human ADRD brain tissue, medicinal chemistry support for development of new compounds and improvement of existing ligand specificity and selectivity, initial screening of ligands in appropriate animal...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 11, 2018 Category: Research Source Type: funding
Alzheimer's-focused administrative supplements for NIH grants that are not focused on Alzheimer's disease
Notice NOT-AG-18-039 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 26, 2018 Category: Research Source Type: funding
